Isaac Shiri Lord
@isaacshiri
Followers
255
Following
1K
Media
2
Statuses
167
Head of Artificial Intelligence in Cardiovascular Medicine at University Hospital Bern @inselgruppe
Berne, Switzerland
Joined June 2012
Clinical performance studies were reported for approximately half of @US_FDA-approved #AI-enabled medical devices, but information was often insufficient to fully assess their clinical generalizability. https://t.co/3laQHbJ4PD
0
3
4
🚀 Check out our recent paper published in @JAMANetworkOpen Generalizability of FDA-Approved AI-Enabled Medical Devices for Clinical Use ⬇️⬇️⬇️ Giovanni Baj @isaacshiri Pooya Kazaj @CheesemakerMD @chrisgraeni George Siontis https://t.co/ORPZx7VIuh
jamanetwork.com
This cross-sectional study describes key characteristics of medical devices using artificial intelligence (AI) approved by the US Food and Drug Administration (FDA) relevant to their clinical...
1
13
16
Among patients with an anomalous aortic origin of the right coronary artery, coronary artery CT can be used to safely risk stratify individuals @chrisgraeni @inselgruppe @BernCVRC @13Kakiz @yasushiueki @biglermarius @Fbiccire @isaacshiri @chrisgraeni
https://t.co/50QNuA5lZA
1
11
23
New publication: “Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis”. Congratulations to the authors! https://t.co/4KMMon8EDS
@chrisgraeni #BernCVRC
pubmed.ncbi.nlm.nih.gov
Artificial intelligence-based models using collected pre-TAVI evaluation data can effectively detect ATTR-CM in patients with severe AS, offering an alternative diagnostic strategy to scintigraphy...
0
2
5
Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. https://t.co/omyCTyiBxW
#JACC @chrisgraeni
5
67
190
🚨 Excited: Our paper in @JACCJournals on #Myocarditis"! 🔍 We compared Myo-criteria in 1,557 undergoing #whyCMR🧲 ❗️89%#ESC, 29%#LLC ❗️LLC➡️event rates (6.6%/yr) ❗️Negative ESC➡️great prognosis (0.7%yr) 💡 ESC & LLC complement diagnosis & risk
2
3
7
🔊Listen to this excellent podcast by @drjohnm in @Medscape about our meta-analysis of #whyCMR in #NIDCM, published in @JAMA_current
https://t.co/DCbWlyRrWV
@DrChrisEichhorn @isaacshiri @RKwongMD @inselgruppe @BernCVRC @MedFacultyUniBE @BWHCVImaging @Harvard
medscape.com
Surgical clearance, NICM assessment, dueling perspectives on PCI as first-line therapy for angina, GDMT in HFrEF are the topics John Mandrola, MD, discusses in this week’s podcast.
0
3
11
What is the association of #CMR –derived measurements with clinical outcomes in nonischemic dilated cardiomyopathy? Read the journal scan to find out! 👇
acc.org
Debabrata Mukherjee, MD, FACC
0
2
8
Meta-analysis examined the value of cardiac MRI–derived measurements for risk stratification in patients with nonischemic dilated cardiomyopathy. The presence and extent of late gadolinium enhancement were associated with adverse clinical outcomes. https://t.co/mtsUjkoLv6
1
3
14
Meta-analysis examined the value of cardiac MRI–derived measurements for risk stratification in patients with nonischemic dilated cardiomyopathy. The presence and extent of late gadolinium enhancement were associated with adverse clinical outcomes. https://t.co/mtsUjkoLv6
0
3
7
🫀Neue Studie unter Leitung der @inselgruppe, #unibern zeigt dass ein Herz-MRT die Risikobeurteilung bei Herzschwäche erheblich verbessert. Der Nachweis von Narbengewebe gilt als Schlüsselfaktor für die Prognose. @MedFacultyUniBE @chrisgraeni
Spannende News: Meta-Analyse in @JAMA_current von @chrisgraeni #InselGruppe @unibern zeigt, warum #CMR für #NIDCM wichtig ist! Mehr: https://t.co/Vd5gMHyAiN
@MedFacultyUniBE
@DrChrisEichhorn
@isaacshiri
@DrMArdissino
@jens_eckstein
@RKwong
0
2
5
So excited - my first coauthored paper in JAMA came out today! 🎉 ➡️ In our meta-analysis, presence & extent of LGE, but not LVEF, were associated with adverse clinical outcomes including mortality and arrhythmic death in non-ischaemic DCM https://t.co/ZIyBjApCQU
jamanetwork.com
This meta-analysis investigates the association of various cardiac MRI–derived measurements with adverse clinical outcomes in patients with nonischemic dilated cardiomyopathy for the purpose of risk...
2
4
37
Exciting🚀: Metaanalysis published in @JAMA_current. 🫀 Is #whyCMR 🧲linked to outcomes in #NIDCM? 🔎103 studies, 29,788 patients: ❗️LGE➕/extent predicted arrhythmia &🪦 ‼️LVEF didn’t predict mortality. —> More data needed on T1, ECV, GLS. @DrChrisEichhorn @isaacshiri @RKwong
Exciting news: Meta-analysis in @JAMA_current by @chrisgraeni #InselGruppe @unibern shows #whyCMR is crucial for #NIDCM outcomes! Read more: https://t.co/y8nO6FsSEj
@MedFacultyUniBE
@DrChrisEichhorn
@isaacshiri
@DrMArdissino
@jens_eckstein
@Rkwong
1
11
27
Spannende News: Meta-Analyse in @JAMA_current von @chrisgraeni #InselGruppe @unibern zeigt, warum #CMR für #NIDCM wichtig ist! Mehr: https://t.co/Vd5gMHyAiN
@MedFacultyUniBE
@DrChrisEichhorn
@isaacshiri
@DrMArdissino
@jens_eckstein
@RKwong
0
2
5
Exciting news: Meta-analysis in @JAMA_current by @chrisgraeni #InselGruppe @unibern shows #whyCMR is crucial for #NIDCM outcomes! Read more: https://t.co/y8nO6FsSEj
@MedFacultyUniBE
@DrChrisEichhorn
@isaacshiri
@DrMArdissino
@jens_eckstein
@Rkwong
0
6
14
🌟 Fantastic experience at #ESC24 @escardio in #London! Great to reconnect with friends & colleagues 🙏🏻 ❗️12 presentations, chairs, & abstracts by our #CardiacImaging / #ArtificialIntelligence @MedFacultyUniBE @inselgruppe ‼️@isaacshiri won the Young Investigator Award! 🏆👏
1
2
16
Adrien Depeursinge, Mario Jreige, and Vincent Andrearczyk will give a tutorial on Radiomics at the European Workshop on Visual Information Processing (EUVIP) 2024, Sunday, 8th September in Geneva University Hospital. Registration here: https://t.co/JTwGdyNvtp
0
1
1
🎯#AI introduces robust solutions for clinical / research workflows plus #CVImaging & others markers that generates novel #data dimensions in #Healthcare! Read&Share - https://t.co/NT7VK4MFRB 🏆A #IJCVI review by Gennari, Rossi, @DeCeccoCN, @marly_van_assen, Sartoretti,
🚀 #AI in #CACS Supplements #ASCVD risk assessment in <1 min 🎯 Enhances accuracy of risk assessments 🤖 Promises personalized therapy & reduces medical workload @DeCeccoCN @AlexiaRossi04 @marly_van_assen @chrisgraeni @ShehabAnwer @IJCVImaging #YesCCT
0
5
10
🎯The #IJCVI EiC, Christoph Gräni (@chrisgraeni)❓ What drove your choice of these five standout articles, which highlight how #YesCCT is transforming #TAVI planning ⁉️🌐 https://t.co/8rupwqzEup
@domcbenz @RaberLorenz @ARrosendael @isaacshiri @MarcoGuglielmo @EdoardoConte16
1
6
10